Skip to content

Clinical Effect of Platelet Rich Plasma Combined With Laser on Scar

Clinical Study on Efficacy and Safety of Platelet Rich Plasma Combined With Laser for Scar Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02396290
Enrollment
29
Registered
2015-03-24
Start date
2013-03-31
Completion date
2013-09-30
Last updated
2015-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Scar

Keywords

acne scar, fractional carbon dioxide laser, platelet rich plasma

Brief summary

Investigation of Clinical Effect of Platelet Rich Plasma Combined With Laser on Acne Scar

Detailed description

Platelet Rich Plasma may relieve the adverse effect of laser treatment. and it can be expected to improve acne treatment result.

Interventions

PROCEDUREfractional carbon dioxide laser with platelet rich plasma

fractional carbon dioxide laser followed by platelet rich plasma injection

PROCEDUREfractional carbon dioxide laser with NS

fractional carbon dioxide laser followed by normal saline injection

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* moderate to severe acne scar

Exclusion criteria

* taken procedures for acne scar within 6 months * underlying diabetes mellitus, keloid, or malignancy

Design outcomes

Primary

MeasureTime frameDescription
Global assessment of acne scar12 weeks5-point grading of acne scar

Secondary

MeasureTime frameDescription
ECCA (échelle d'évaluation clinique des cicatrices d'acné)12 weeksquantitative analysis of acne scar
adverse effect assessment12 weeksadverse effect assessment - erythema index, Epithelization Scale (0-12 point)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026